Legend Biotech reported significant growth across key metrics in Q2 2025, with CARVYKTI leading the charge. The therapy generated $439 million in net trade sales, representing a 136% year-over-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback